Skip to main content
. 2023 Feb 23;9(4):500–510. doi: 10.1001/jamaoncol.2022.7476

Figure. Kaplan-Meier Plots Showing Overall Survival by Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2)–Low Status in Patients With Triple-Negative Breast Cancer (TNBC) and Hormone Receptor–Positive Breast Cancer .

Figure.

Kaplan-Meier survival curves are illustrated by stage and hormone receptor status for ERBB2-low vs ERBB2-negative breast cancer.